WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
Start: 16 Oct 2020 09:31 GMT
End: 16 Oct 2020 09:33 GMT
GENEVA, SWITZERLAND - WHO spokesman Tarik Jašarević reads statement on Gilead Sciences Inc's remdesivir having little or no effect on COVID-19 patients' length of hospital stay or chances of survival, according to a clinical trial by the World Health Organization (WHO).
Restrictions:
BROADCAST: NONE
DIGITAL: NONE
Source: REUTERS
Aspect Ratio: 16:9
Location: Switzerland
Topic: Science / Technology
Audio: NATURAL / ENGLISH
Editorial Support: +44 20 7542 2244
Email: tvnews@thomsonreuters.com
Últimas Noticias
México reporta 189.830 repatriados desde el retorno de Trump a la Casa Blanca
Meloni: Europa se "durmió" en un "mundo dorado" de dependencia de EE. UU., Rusia y China
La OMC vaticina que la economía europea puede ser la más perjudicada por la guerra de Irán
Venecia restaura a la vista del público el icónico Retablo de San Job de Bellini
Rusia pide evitar ataques a la central de Bushehr y alerta del impacto "regional" en caso de "accidente grave"
